[Dilip Davda] IPL is in the pharma and healthcare segment and has posted growth in its top and bottom lines for the reported periods. Super earnings for FY23 H1 raise eyebrows and concern over the sustainability of such margins going forward. Well-informed investors may park funds for medium to long-term rewards. Read detail review...

Infinium Pharmachem IPO Review by Members

Infinium Pharmachem IPO Reviews, analysis and views by popular members. Read Infinium Pharmachem Ltd. IPO reviews by retail investors to find recommended ipo to buy.

Infinium Pharmachem IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	0	0
%	0.00	0.00	0.00	0.00

Member	Review
No recommendation found. Be the first to post the recommendation.

Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.

Infinium Pharmachem IPO Review & Recommendations

Infinium Pharmachem IPO Review Summary from brokers and analysts

Infinium Pharmachem IPO Review by Dilip Davda May apply

Infinium Pharmachem IPO Review by Members

Infinium Pharmachem IPO Review Summary by Members

Read more about Infinium Pharmachem IPO